- December 13, 2025
-
-
Loading
Loading
About one year ago, executives at NeoGenomics quietly changed their company's vision statement.
But the change was hardly insignificant. Previously, Fort Myers-based NeoGenomics' vision was to be the nation's leading cancer-testing company. Now, the company has global ambition.
“Part of our vision is to be the world's leading cancer-testing company,” says Douglas VanOort, the company's chairman and CEO. “We're well on our way to that.”
